Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul 13;326(2):129-130.
doi: 10.1001/jama.2021.9486.

Progress in Pharmacotherapy for Obesity

Susan Z Yanovski  1 , Jack A Yanovski  2
Affiliations

Progress in Pharmacotherapy for Obesity

Susan Z Yanovski et al. JAMA. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

SZY reports no conflicts of interest. JAY reports that he is a site Principal Investigator for two multi-center trials of medications for treatment of genetic obesities conducted under CRADAs between NICHD and Soleno Therapeutics Inc (diazoxide choline-controlled release) and between NICHD and Rhythm Pharmaceuticals Inc (setmelanotide).

References

    1. Yanovski SZ, Yanovski JA. Naltrexone extended-release plus bupropion extended-release for treatment of obesity. JAMA. 2015;313(12):1213–1214. - PMC - PubMed
    1. Yanovski SZ, Yanovski JA. Long-term drug treatment for obesity: a systematic and clinical review. JAMA. 2014;311(1):74–86. - PMC - PubMed
    1. Khera R, Murad MH, Chandar AK, et al. Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events: A Systematic Review and Meta-analysis. JAMA. 2016;315(22):2424–2434. - PMC - PubMed
    1. Garvey WT, Birkenfeld AL, Dicker D, et al. Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial. Diabetes Care. 2020;43(5):1085–1093. - PMC - PubMed
    1. Kelly AS, Auerbach P, Barrientos-Perez M, et al. A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity. N Engl J Med. 2020;382(22):2117–2128. - PubMed

Publication types

MeSH terms